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ABSTRACT
Becker Disease is an autosomal recessive version of the rare congenital disorder called Myotonia Congenita. Due to 
the rarity of Becker Disease, the genetic and pathological basis of this disease have not been studied well and 
possible diagnostic methods and techniques are yet to be explored. The existing method of diagnosis of such a case 
is predominantly dependent on the clinical examination. More work and studies need to be done on the diagnostic 
aspect of this disease to discover newer diagnostic methods for this disease, which are more reliable and speciﬁc. In 
order to develop better diagnostic methods for the disease, more cases of Becker disease need to be reported, with 
details of clinical and structural abnormalities. Here, we present the case report of a seven year old boy who has a 
history and clinical ﬁndings suggestive of Becker disease. Identiﬁcation of this and similar cases of Becker disease 
can help us better understand this disease and hopefully one day help us develop a treatment for it.
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INTRODUCTION
Myotonia Congenita is a rare genetic disease and it 
affects 1 in 100,000 individuals.[1]  Its symptoms begin 
to appear in early childhood and are characterized by 
defects in the skeletal muscle membrane which leads 
to delayed muscle relaxation, stiffness and weakness 
of the muscles. It has two subtypes, an autosomal 
dominant type (Thomsen Disease) and an autosomal 
recessive type (Becker disease).[2] The symptoms are 
more severe in the recessive form of this disease than 
the dominant form, where the transient weakness and 
stiffness of the muscle is more severe especially after 
prolonged periods of rest.[3] These patient also suffer 
from painless muscle stiffness, which can be relieved 
by activity (a method known as the warm-up 
phenomenon).[4] Moreover, these individuals have 
muscular hypertrophy, specially in the limbs, which 
gives them an athletic look.[3] The diagnosis of Becker 
disease is dependent on clinical symptoms and signs 
like muscle stiffness, delayed muscle relaxation, 
difﬁculty swallowing and alleviation of stiffness after  
br ief  exercise.[3]  Electromyogram in these
patients shows myotonic bursts.[3] Sequence coding 
CLCN1 gene can help identify 95% of cases.[3]  
The genetic mutations responsible for Becker disease 
have been identiﬁed to occur in CLCN1 gene, which 
encodes for a chloride channel in a normal muscle 
membrane.[3] This gene resides on chromosome 
7q35.[5] It is responsible for the formation of voltage 
dependent chloride channels, which in turn control the 
movement of chloride ions into and out of cells.[5] This 
abnormality therefore leads to all the symptoms 
mentioned above. However, as one particular study 
suggests that there can be as many as 130 different 
mutations in the CLCN1 gene that are responsible for 
this condition, this diversity in mutations could be the 
reason why no two cases of Becker disease present in 
the exact same manner.[6] Hence it is essential to 
determine the most common mutations and then to 
investigate the association of those mutations to their 
particular clinical presentations. In order to achieve 
this goal more studies need to be conducted after 
receiving samples from new conﬁrmed cases of 
Becker Disease. 
CASE PRESENTATION
Here we present the case of a 7 year old boy who 
presented to Aga Khan University Hospital, Karachi 
Pakistan, in 2016, with complains of difﬁculty in walking 
and weakness of muscles, speciﬁcally in the lower 
limbs. His symptoms were ﬁrst notice by the father, 
who stated that the patient has had walking difﬁculties 
since he was 5 years old. On inquiring, it was reported 
that the patient suffered from episodes of muscle 
stiffness after prolonged episodes of rest and he was 
unable to walk in a straight line.
On examination, the patient appeared to be restless 
and weak. He had weakness of the proximal muscles 
of hips and thighs bilaterally. No muscle wasting, no 
hypertonia and no atonia was observed. However, the 
pathognomonic hypertrophy of calf muscle seen in 
patients of myotonia congenita was also observed in 
this patient. Eye examination revealed that he was also 
hyperopic.
Electromyography studies showed diffuse myotonia in 
all muscles examined in the upper and lower 
extremities. Evaluation of voluntary motor unit action 
potentials was hampered by the presence of profound 
myotonia. There was no deﬁnite evidence of 
myopathy. Blood tests showed that Vitamin D levels 
were 20.3ng/ml.
Based on patient history, clinical examination and 
electromyography test, the patient was diagnosed to 
be suffering from Becker disease. The parents were 
educated about this debilitating disease. Due to the 
non-availability of any signiﬁcantly effective treatment, 
the patient was advised to get regular physiotherapy 
and prescribed Vitamin D supplements.  
DISCUSSION
Myotonia Congenita, a musculoskeletal disorder, was 
ﬁrst identiﬁed with seminal studies by Bryant, Lipicky 
[6]
and colleagues in 1960.  It was in the 1990s, when the 
ﬁrst CLCN1 gene mutations were discovered and 
along with it the autosomal dominant and recessive 
[7] 
components of this disease were identiﬁed. CLCN1 
gene in the body is responsible for normal production 
of proteins that which controls the chloride channels in 
the skeletal muscle ﬁber, which then assist in normal 
[8]
muscle contraction and relaxation.  Mutations in this 
gene hence leads to alteration in the chloride 
channels, which in turn reduces the movement of ions 
[9]
across the membrane.  It is believed that mutations in 
the CLCN1 gene are responsible for both autosomal 
recessive (Becker disease) and dominant versions 
(Thomsen disease) of Myotonia Congenita. In fact one 
study has identiﬁed as many as 130 mutations in the 
[ 6 ]
CLCN1 gene.  Hence the precise mutations 
responsible for Becker and Thomsen diseases are yet 
to be discovered. 
In order to treat this condition it is important to 
determine the extent of this disease. A genetic 
counselor and neurologist should be taken on board to 
decide how progressed the disease is and what 
[ 3 ]
treatment regimen should be used.  A few 
pharmacological treatments are being tested for 
Myotonia Congenita. A randomized double blinded trial 
showed that mexiletine reduced muscle stiffness in 59 
patients with Myotonia and 34 patients out of these 
[9]
suffered from Myotonia Congenita.  It has also been 
suggested that other compounds, such as quinine, 
dantrolene, acetazolamide, carbamezapine or 
[10]
phenytoin,  can be tried to reduce the symptoms. 
However, looking at the symptoms of this condition 
anesthetic agents and depolarizing muscle relaxants 
[3]
should be used with care.  One study also reported 
that beta-antagonist propranolol worsen the 
symptoms of Myotonia Congenita, hence it should be 
avoided.
We have reported the ﬁrst case of Becker disease (an 
autosomal recessive form of Myotonia Cogenita) from 
Pakistan. This is a rare disease that should be reported 
so that more research can be conducted on its genetic 
basis and for the discovery of its treatment. 
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